*Corresponding author:
Chonkar Sonali, Staff Physician, KK Women’s and Children’s Hospital, SingaporeReceived: April 07, 2018; Published: April 23, 2018
DOI: 10.26717/BJSTR.2018.04.000989
To view the Full Article Peer-reviewed Article PDF
Pregnancy has been known to put women in a hypercoagulable state. This has been postulated to be the body’s physiological response to the maternal’s susceptibility to bleeding risks during the antenatal and postnatal period [1-3]. Thus, pregnant women are four to five times more likely to develop venous thromboembolism (VTE) [4], putting the incidence to about 0.71 per 1000 pregnancies [4]. VTE is known to affect pregnant women from 1st trimester up to post partum [5] with the risk of VTE being higher as the woman progresses later in her pregnancy [6]. VTE in pregnancy is also more known to affect the left lower limb than the right, with a weighted event rate of 77.2% for left sided or bilateral lower limb deep vein thrombosis and 21.5% for right sided deep vein thrombosis [5]./p>